-
EP3223854
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3223854
| EP3223854 - PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 22.10.2019 Database last updated on 12.07.2024 | |
| Former | Request for examination was made Status updated on 01.09.2017 | ||
| Former | The international publication has been made Status updated on 23.06.2017 | Most recent event Tooltip | 22.06.2024 | New entry: Application deemed to be withdrawn: despatch of communication + time limit | Applicant(s) | For all designated states ADC Therapeutics SA Route de la Corniche 3B 1066 Epalinges / CH | For all designated states Medimmune Limited Milstein Building Granta Park Cambridge, Cambridgeshire CB21 6GH / GB | [2017/40] | Inventor(s) | 01 /
VAN BERKEL, Patricius Henrikus Cornelis ADC Therapeutics Sàrl route de la Corniche 3B 1006 Epalinges / CH | 02 /
HOWARD, Philip Wilson MedImmune Limited Riverside Building Granta Park Cambridge Cambridgeshire CB1 7PH / GB | 03 /
HARTLEY, John UCL Cancer Institute Paul O'Gorman Building 72 Huntley Street London WC1E 6BT / GB | [2017/40] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [N/P] |
| Former [2017/40] | Andrews, Robert, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | Application number, filing date | 15801398.7 | 25.11.2015 | [2017/40] | WO2015EP77684 | Priority number, date | GB20140020910 | 25.11.2014 Original published format: GB 201420910 | GB20150013605 | 31.07.2015 Original published format: GB 201513605 | [2017/40] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016083468 | Date: | 02.06.2016 | Language: | EN | [2016/22] | Type: | A1 Application with search report | No.: | EP3223854 | Date: | 04.10.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.06.2016 takes the place of the publication of the European patent application. | [2017/40] | Search report(s) | International search report - published on: | EP | 02.06.2016 | Classification | IPC: | A61K47/50, A61P35/00 | [2017/40] | CPC: |
A61K31/5517 (EP,CN,US);
A61K47/6849 (EP,KR,US);
A61K47/68035 (EP,CN,KR,US);
A61K47/6889 (EP,US);
A61P35/00 (EP);
A61P35/04 (EP);
C07K16/2866 (US);
C07K2317/21 (US);
C07K2317/56 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/40] | Title | German: | PYRROLOBENZODIAZEPIN-ANTIKÖRPER-KONJUGATE | [2017/40] | English: | PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES | [2017/40] | French: | CONJUGUÉS ANTICORPS-PYRROLOBENZODIAZÉPINE | [2017/40] | Entry into regional phase | 23.06.2017 | National basic fee paid | 23.06.2017 | Designation fee(s) paid | 23.06.2017 | Examination fee paid | Examination procedure | 23.06.2017 | Examination requested [2017/40] | 23.06.2017 | Date on which the examining division has become responsible | 18.01.2018 | Amendment by applicant (claims and/or description) | 25.10.2019 | Despatch of a communication from the examining division (Time limit: M06) | 29.04.2020 | Reply to a communication from the examining division | 07.04.2021 | Despatch of a communication from the examining division (Time limit: M04) | 25.05.2021 | Reply to a communication from the examining division | 21.06.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time | Fees paid | Renewal fee | 27.11.2017 | Renewal fee patent year 03 | 23.11.2018 | Renewal fee patent year 04 | 12.11.2019 | Renewal fee patent year 05 | 24.11.2020 | Renewal fee patent year 06 | 18.11.2021 | Renewal fee patent year 07 | 18.11.2022 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 30.11.2023 | 09 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Rights in Rem or Legal Means of Execution | ID: | 01 | For: | AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR | Date: | 24.06.2020 | ID: | 02 | For: | AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR | Date: | 07.10.2022 | [2023/01] |
| Former [2020/47] | ID: | 01 | |
| For: | AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR | ||
| Date: | 24.06.2020 | ||
| [2023/01] | Cited in | International search | [YDA]WO2014057119 (ADC THERAPEUTICS S RL [CH]); | [A]WO2014057120 (ADC THERAPEUTICS S RL [CH]); |